Objective: Intradural spinal hemangioblastoma are infrequent, vascular, pathologically benign tumors occurring either sporadically or in association with von Hippel-Lindau disease along the neural axis. Described in fewer than 1,000 cases, literature is variable with respect to epidemiological factors associated with spinal hemangioblastoma and their treatment. The objective of this study was to evaluate the epidemiology of intradural spinal hemangioblastoma with the Surveillance, Epidemiology and End Results (SEER) database while also presenting an illustrative case. Methods: The SEER database was queried for cases of spinal hemangioblastoma between 2000 and 2010 with the use of SEER*Stat software. Incidence was evaluated as a function of age, sex and race. Survival was evaluated with the Cox proportionate hazards ratio using IBM SPSS software evaluating age, sex, location, treatment modality, pathology and number of primaries (p = 0.05). Descriptive statistics of the same factors were also calculated. The case of a 43-year-old patient with a surgical upper cervical intramedullary hemangioblastoma is also presented. Results: In the data set between 2000 and 2010, there were 133 cases with an age-adjusted incidence of 0.014 (0.012-0.017) per 100,000 to the standard USA population. Hemangioblastoma was the tenth most common intradural spinal tumor type representing 2.1% (133 of 6,156) of all spinal tumors. There was no difference in incidence between men and women with an female:male rate ratio of 1.05 (0.73-1.50) with p = 0.86. The average age of patients was 48.0 (45.2-50.9) years, and a lower incidence was noted in patients <15 years compared to all other age groups (p < 0.05). There was no difference in incidence amongst the different races. Treatment included surgical resection in 106 (79.7%) cases, radiation with surgery in 7 (5.3%) cases, and radiation alone was used in only 1 (0.8%) case, and no treatment was performed in 17 (12.8%) cases. Mortality was noted in 12 (9%) cases, and median survival of 27.5 months (range 1-66 months) over the 10-year period. Mortality was attributable to the malignancy in 3 (2%) cases. There was no statistically significant different in Cox hazard ratios for mortality for sex, race, treatment modality, pathology or number of primaries. Conclusions: Spinal hemangioblastoma represent a small fraction of primary intradural spinal tumors, and this study did not identify any difference in incidence between genders. Surgical treatment alone was the most common treatment modality. Overall prognosis is good, with 9% observed mortality over the 10-year period, with 2% mortality attributable to the malignancy.

Deng X, Wang K, Wu L, Yang C, Yang T, Zhao L, Yang J, Wang G, Fang J, Xu Y: Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article. J Neurosurg Spine 2014;21:260-269.
Mandigo CE, Ogden AT, Angevine PD, McCormick PC: Operative management of spinal hemangioblastoma. Neurosurgery 2009;65:1166-1177.
Lonser RR, Oldfield EH: Microsurgical resection of spinal cord hemangioblastomas. Neurosurgery 2005;57(4 suppl):372-376.
Selch MT, Tenn S, Agazaryan N, Lee SP, Gorgulho A, De Salles AA: Image-guided linear accelerator-based spinal radiosurgery for hemangioblastoma. Surg Neurol Int 2012;3:73.
Daly ME, Choi CY, Gibbs IC, Adler JR Jr, Chang SD, Lieberson RE, Soltys SG: Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. Int J Radiat Oncol Biol Phys 2011;80:213-220.
Moss JM, Choi CY, Adler JR Jr, Soltys SG, Gibbs IC, Chang SD: Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas. Neurosurgery 2009;65:79-85; discussion 85.
Ryu SI, Kim DH, Chang SD: Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus 2003;15:E10.
Biondi A, Ricciardi GK, Faillot T, Capelle L, Van Effenterre R, Chiras J: Hemangioblastomas of the lower spinal region: report of four cases with preoperative embolization and review of the literature. AJNR Am J Neuroradiol 2005;26:936-945.
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D: Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 2001;48:55-62; discussion 62-63.
Lee DK, Choe WJ, Chung CK, Kim HJ: Spinal cord hemangioblastoma: surgical strategy and clinical outcome. J Neurooncol 2003;61:27-34.
Serban D, Exergian F: Intramedullary hemangioblastoma - local experience of a tertiary clinic. Chirurgia (Bucur) 2013;108:325-330.
Park CH, Lee CH, Hyun SJ, Jahng TA, Kim HJ, Kim KJ: Surgical outcome of spinal cord hemangioblastomas. J Korean Neurosurg Soc 2012;52:221-227.
Harati A, Satopaa J, Mahler L, Billon-Grand R, Elsharkawy A, Niemela M, Hernesniemi J: Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel-Lindau disease. Surg Neurol Int 2012;3:6.
Imagama S, Ito Z, Wakao N, Sakai Y, Kato F, Yukawa Y, Sato K, Ando K, Hirano K, Tauchi R, Muramoto A, Hashizume Y, Matsuyama Y, Ishiguro N: Differentiation of localization of spinal hemangioblastomas based on imaging and pathological findings. Eur Spine J 2011;20:1377-1384.
Takai K, Taniguchi M, Takahashi H, Usui M, Saito N: Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir (Tokyo) 2010;50:560-567.
Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR: Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease. J Neurosurg Spine 2010;12:233-242.
Clark AJ, Lu DC, Richardson RM, Tihan T, Parsa AT, Chou D, Barbaro NM, Kunwar S, Weinstein PR, Lawton MT, Berger MS, McDermott MW: Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg 2010;74:200-205.
Parker F, Aghakhani N, Ducati LG, Yacubian-Fernandes A, Silva MV, David P, Richard S, Tadie M: Results of microsurgical treatment of medulla oblongata and spinal cord hemangioblastomas: a comparison of two distinct clinical patient groups. J Neurooncol 2009;93:133-137.
Kanno H, Yamamoto I, Nishikawa R, Matsutani M, Wakabayashi T, Yoshida J, Shitara N, Yamasaki I, Shuin T: Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord 2009;47:447-452.
Shin DA, Kim SH, Kim KN, Shin HC, Yoon DH: Surgical management of spinal cord haemangioblastoma. Acta Neurochir (Wien) 2008;150:215-220; discussion 220.
Bostrom A, Hans FJ, Reinacher PC, Krings T, Burgel U, Gilsbach JM, Reinges MH: Intramedullary hemangioblastomas: timing of surgery, microsurgical technique and follow-up in 23 patients. Eur Spine J 2008;17:882-886.
Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH: Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 2003;98:106-116.
Hsu S, Quattrone M, Ostrom Q, Ryken TC, Sloan AE, Barnholtz-Sloan JS: Incidence patterns for primary malignant spinal cord gliomas: a Surveillance, Epidemiology, and End Results Study. J Neurosurg Spine 2011;14:742-747.
Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim ES: Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc 2007;42:436-440.
Van Velthoven V, Reinacher PC, Klisch J, Neumann HP, Glasker S: Treatment of intramedullary hemangioblastomas, with special attention to von Hippel-Lindau disease. Neurosurgery 2003;53:1306-1313; discussion 1313-1314.
Lefranc F, Brotchi J: Surgical strategy in spinal cord hemangioblastomas. Oper Tech Neurosurg 2003;6:24-31.
Xu Q, Bao W, Pang L: Diagnosis and treatment of intramedullary hemangioblastoma of cervical spinal cord. Chin Med J (Engl) 2002;115:1010-1013.
Malis LI: Atraumatic bloodless removal of intramedullary hemangioblastomas of the spinal cord. J Neurosurg 2002;97(1 suppl):1-6.
Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI: Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 2001;49:321-327; discussion 327-328.
Pietila TA, Stendel R, Schilling A, Krznaric I, Brock M: Surgical treatment of spinal hemangioblastomas. Acta Neurochir (Wien) 2000;142:879-886.
Hirano K, Imagama S, Sato K, Kato F, Yukawa Y, Yoshihara H, Kamiya M, Deguchi M, Kanemura T, Matsubara Y, Inoh H, Kawakami N, Takatsu T, Ito Z, Wakao N, Ando K, Tauchi R, Muramoto A, Matsuyama Y, Ishiguro N: Primary spinal cord tumors: review of 678 surgically treated patients in Japan. A multicenter study. Eur Spine J 2012;21:2019-2026.
Ngwenya LB, Chiocca EA: Editorial: meningioma and radiotherapy. J Neurosurg 2012;117:666-668.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.